Biological toxicity of nanoparticles

dc.contributor.authorTaliyan, Rajeev
dc.date.accessioned2023-12-13T08:50:41Z
dc.date.available2023-12-13T08:50:41Z
dc.date.issued2022
dc.description.abstractMultiple biological barriers and discrepancy in releasing the optimal dosage range pose a great challenge in the current therapeutic management for majority of diseases. Nanoparticle drug delivery system (5–250 nm) possesses the capacity to overcome such difficulties making it an incredible choice for disease management. Various types of nanoparticles are readily available in the market each possessing its own unique characteristics, however, based on their size, shape, and surface reactivity, they can inflict certain type of toxicity, the most common being biological toxicity to human tissue and to cell culture. The toxicity can further lead to an enhanced level of oxidative stress and inflammatory cytokine. Hence, in the following chapter, we discuss the various types of nanoparticles available, its importance in the clinical field and a detailed understanding on the biological toxicity of nanoparticles.en_US
dc.identifier.urihttps://www.sciencedirect.com/science/article/abs/pii/B9780128207574000168
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13396
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectPharmacyen_US
dc.subjectNanoparticle drug delivery systemen_US
dc.titleBiological toxicity of nanoparticlesen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: